The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Larissa Arning

Department of Human Genetics

Ruhr-University Bochum

Germany

[email]@rub.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Human Genetics, Ruhr-University Bochum, Germany. 2004 - 2011

References

  1. PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Taherzadeh-Fard, E., Saft, C., Akkad, D.A., Wieczorek, S., Haghikia, A., Chan, A., Epplen, J.T., Arning, L. Mol. Neurodegener (2011) [Pubmed]
  2. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. Arning, L., Haghikia, A., Taherzadeh-Fard, E., Saft, C., Andrich, J., Pula, B., Höxtermann, S., Wieczorek, S., Akkad, D.A., Perrech, M., Gold, R., Epplen, J.T., Chan, A. J. Mol. Med. (2010) [Pubmed]
  3. PGC-1alpha as modifier of onset age in Huntington disease. Taherzadeh-Fard, E., Saft, C., Andrich, J., Wieczorek, S., Arning, L. Mol. Neurodegener (2009) [Pubmed]
  4. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease. Arning, L., Monté, D., Hansen, W., Wieczorek, S., Jagiello, P., Akkad, D.A., Andrich, J., Kraus, P.H., Saft, C., Epplen, J.T. J. Mol. Med. (2008) [Pubmed]
  5. Identification and characterisation of a large senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2). Arning, L., Schöls, L., Cin, H., Souquet, M., Epplen, J.T., Timmann, D. Neurogenetics (2008) [Pubmed]
  6. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner. Arning, L., Saft, C., Wieczorek, S., Andrich, J., Kraus, P.H., Epplen, J.T. Hum. Genet. (2007) [Pubmed]
  7. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Arning, L., Kraus, P.H., Valentin, S., Saft, C., Andrich, J., Epplen, J.T. Neurogenetics (2005) [Pubmed]
  8. Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD). Arning, L., Kraus, P.H., Saft, C., Andrich, J., Epplen, J.T. BMC Med. Genet. (2005) [Pubmed]
  9. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease. Arning, L., Jagiello, P., Wieczorek, S., Saft, C., Andrich, J., Epplen, J.T. BMC Med. Genet. (2004) [Pubmed]
 
WikiGenes - Universities